Journal Information
Images in Paediatrics
Full text access
Available online 24 October 2024
Erythema multiforme major/Stevens-Johnson syndrome: a diagnostic challenge
Eritema multiforme mayor/síndrome de Stevens-Johnson: un desafío diagnóstico
Visits
195
Rita Lages Pereiraa,
Corresponding author
, Mariana Oliveira Pereiraa, Carmo Ferreirab, Ivo Nevesa
a Servicio de Pediatría, Hospital de Braga, Braga, Portugal
b Unidad de Cuidados Intermedios Pediátricos, Hospital de Braga, Braga, Portugal
This item has received
Received 31 March 2024. Accepted 12 June 2024
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (1)
Table 1. Comparison of the clinical features of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Full Text

A male adolescent aged 14 years presented with fever, conjunctivitis, sore throat, oral ulcers, swollen lips and rash with onset 5 days prior. On day 2, a throat swab tested positive for group A Streptococcus, and amoxicillin and ibuprofen were prescribed. On day 5, the rash worsened (Fig. 1) with extensive mucosal involvement (Fig. 2). There was no history of recent infection or drug intake compatible with the symptoms. At this point, Stevens-Johnson syndrome (SJS) or erythema multiforme major (EMM) were suspected. The treatment included intravenous immunoglobulin (1 g/kg/day) for 4 days and methylprednisolone for 5 days, which achieved progressive improvement. The findings of the skin biopsy supported the diagnosis of SJS (Fig. 3).

Figure 1.

Erythematous macules and some atypical target lesions distributed through the trunk, arms, and legs.

(0.29MB).
Figure 2.

Extensive involvement of the face (A) and palms (B), with erythematous macules and some flaccid blisters in the face. Conjunctivitis with purulent discharge and severe oral mucositis (A).

(0.4MB).
Figure 3.

(A) (×20 magnification) Dermoepidermal detachment with vesiculation and fullthickness epidermal necrosis. (B) (×1 magnification) Interface dermatitis with basal cell vacuolization and apoptotic keratinocytes.

(0.51MB).

In this case, the streptococcal infection and administration of amoxicillin and nonsteroidal anti-inflammatory drugs could have triggered the condition, or the patient may have presented with SJS/EMM at the outset. Distinguishing between EMM and SJS is challenging (Table 1). Both are characterized by widespread rash and mucous membrane involvement. However, EMM usually presents with typical target lesions mainly involving the skin, while SJS manifests with widespread erythematous macules and blisters, often leading to severe skin and mucous membrane detachment, with a higher risk of complications.1–3 In addition, in the case of SJS, two or more mucosal surfaces are usually involve and the patients tend to experience systemic symptoms preceding the cutaneous manifestations.2 Understanding these nuances is essential for accurate diagnosis and timely intervention.

Table 1.

Comparison of the clinical features of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.

  Erythema multiforme major  Stevens–Johnson syndrome 
Cutaneous lesions  Erythematous papules that progress to classic target lesions (dusky central area surrounded by a pale oedematous ring in turn surrounded by an erythematous area)Atypical target lesions may also developCutaneous lesions are usually asymptomatic  Erythematous macules with poorly defined borders that progress to dusky erythema, vesicles and flaccid bullae, followed by skin detachmentAtypical targets may be present (atypical targets have two rings instead of the three typically seen in the EM target lesions) 
Distribution of Lesions  Face and extremities (extensor surfaces of the acral extremities)  Lesions start on the face and thoraxPainful oedematous erythema typically develops on the palms and soles 
Constitutional Symptoms  Uncommon (but can be seen in cases with significant mucosal involvement)  Common (malaise, fever, myalgia, sore throat and conjunctivitis may precede or develop at the same time as the mucocutaneous manifestations) 
Mucosal Involvement  Up to 60%Lesions can involve the oral, ocular and genital mucosae  Severe mucosal involvement; more than one site involved in more than 90% of cases (mostly buccal, oro/nasopharyngeal, and genital mucosae) 
Ocular Involvement  Uncommon  Common (60%–100%) 
Blister Formation  Uncommon  Common 
Precipitating Factors  Most commonly triggered by infection (HSV-1, Mycoplasma)Drugs (<10%) (anti-inflammatory drugs, sulphonamides, antiepileptics and antibiotics)Idiopathic  Most frequently drugs (allopurinol, lamotrigine, anticonvulsants, antibacterial sulphonamides, and cyclooxygenase-2 inhibitor nonsteroidal anti-inflammatory drugs); treatment with the causative drug usually started 1−2 weeks to 1 month prior to the onset of symptomsLess commonly, infection (Mycoplasma <30%)Idiopathic (15%) 
References
[1]
R.D. Goldman.
Erythema multiforme in children.
Can Fam Phys, 68 (2022), pp. 507-550
[2]
R. Frantz, S. Huang, A. Are, K. Motaparthi.
Stevens–johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management.
Medicina (Lithuania), 57 (2021),
[3]
P. Grünwald, M. Mockenhaupt, R. Panzer, S. Emmert.
Erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis – diagnosis and treatment.
J Dtsch Dermatol Ges, 18 (2020), pp. 547-553
Copyright © 2024. Asociación Española de Pediatría
Download PDF
Idiomas
Anales de Pediatría (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?